Additionally, immune reaction and P-gp inhibition were observed by blocking the PD-1/PD-L1 interaction, indicating that checkpoint blockade therapy may contribute to combating chemotherapy resistance in breast cancer. This evidence concerns the gene CD274 and breast cancer.